A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans
Top Cited Papers
- 24 November 2004
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 119 (5), 591-602
- https://doi.org/10.1016/j.cell.2004.11.022
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer RiskAmerican Journal of Human Genetics, 2003
- The p53–Mdm2 module and the ubiquitin systemSeminars in Cancer Biology, 2003
- mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing IrradiationMolecular and Cellular Biology, 2003
- Treatment of malignant hypercalcaemiaExpert Opinion on Pharmacotherapy, 2002
- Sp1 as G1 cell cycle phase specific transcription factor in epithelial cellsOncogene, 2002
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.Journal of Bone and Joint Surgery, 1997
- Recommendations on Predictive Testing for Germ Line p53 Mutations Among Cancer-Prone IndividualsJNCI Journal of the National Cancer Institute, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992